T/CGCPU 006-2022 Active Group standards

T/CGCPU 006-2022 The standard for evaluating clinical trial capability phase I

T/CGCPU 006-2022 The standard for evaluating clinical trial capability phase I

Publish Date: 2022-12-13 Implement Date: 2022-12-26 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CGCPU 006-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2022-12-13
Implement Date: 2022-12-26

Scope

Main technical content: - Preface - Introduction - 1 Scope - 2 Normative reference documents - 3 Terms and definitions, abbreviations 3.1 Terms and definitions 3.2 Abbreviations - 4 Evaluation content 4.1 Phase I clinical trial evaluation content 4.2 Phase I clinical trial capacity evaluation - 5 Evaluation experts - 6 Evaluation process 6.1 Establishment of the evaluation process 6.2 Pre-evaluation workflow 6.3 On-site evaluation process 6.4 Issuance of the evaluation report - 7 Result determination 7.1 Determination of clauses in the evaluation content 7.2 Evaluation conclusions - Appendix A (normative) Evaluation content and evaluation levels - Appendix B (normative) Specific requirements for the evaluation expert group - References

Development Information

Related Standards

Contact Us